This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.






  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Nov. 16, 2011

Home   About The ATA   Join   Fellows' Corner

 
Advertisement


Preterm birth is associated with subsequent hypothyroidism in adult life
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Low birth weight may be a consequence of either delayed fetal growth or preterm birth. Previous studies suggested that low birth weight is associated with thyroid autoimmunity and hypothyroidism in later life, but the potential effect of preterm birth, independent of fetal growth, is unknown. The author's objective was to determine whether preterm birth is independently associated with medically treated hypothyroidism in young adulthood. More

Advertisement
Charting an initial workup of Hypercalcemia

New York Center for Advanced Parathyroid (NYCAP) uses advanced EMR Technologies to chart the evaluation of a patient with new-onset Hypercalcemia. This enables NYCAP to maintain superior results while providing personalized care for each and every patient referred by you.
MORE


Low-dose radioiodine ablation, TSH stimulation warranted in low-risk patients
Endocrine Today (free registration)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Patients at low-risk for recurrence appeared to benefit from the use of recombinant human thyroid-stimulating hormone and low-dose radioiodine ablation after surgery for thyroid cancer, according to data from the ESTIMABL study. More

Survival is similar in high risk thyroid cancer patients treated with radioactive iodine therapy after either thyroid hormone withdrawal or recombinant human TSH
Clinical Thyroidology for Patients    Share    Share on FacebookTwitterShare on LinkedinE-mail article
After the initial surgery for thyroid cancer, many patients are treated with radioactive iodine. Patients are prepared for radioactive iodine treatment by increasing TSH levels, either by stopping thyroid hormone therapy for a period of time and becoming hypothyroid (thyroid hormone withdrawal, THW) or by administering TSH in the form of recombinant human TSH (rhTSH, Thyrogen). More


TSI Reporter BioAssay

•Graves’ disease is the primary cause of hyperthyroidism.

•Graves’ disease is characterized by the presence of thyroid stimulating immunoglobulin (TSI).

•Thyretain TSI Reporter BioAssay is the only commercially available IVD for the detection of TSI, the causative agent of Graves’ disease.

ADVERTISEMENT



Elevated TSH levels common in elderly, but not associated with increased mortality
Endocrine Today (free registration)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Elderly people exhibited slight increases in thyroid-stimulating hormone levels during a 13-year period, yet researchers noted no relationship between these changes and risk for death. "We have a particular interest in looking at subclinical hypothyroidism and what the clinical implications are further down the line, such as whether or not this is something that needs to be treated," Avantika C. Waring, M.D., of the University of California, San Francisco, told Endocrine Today. More

Practice what you preach: There is increasing use of total thyroidectomy for benign disease in the US
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Determining the extent of thyroidectomy for benign disease hinges on the balance of surgical risk and eliminating the need for reoperation for disease recurrence. Academic centers have advocated the safety of total thyroidectomy in experienced hands and have recommended this procedure for the management of benign goiters. Others have argued that even the small added operative risk of total thyroidectomy is unjustified for benign disease. The purpose of this study was to assess whether the use of total thyroidectomy for benign thyroid disease is increasing as advocated by "experts." More


 
ATA Thyroid Weekly News Briefs
ATA does not develop, exert any editorial or other control, or guarantee the accuracy, completeness, efficacy, or timeliness, of the materials, information, advertising or promotional activities ("Content") in this publication. Inclusion of Content in this publication does not constitute or imply endorsement, agreement, recommendation, or favoring by ATA of such information or the entities mentioned or promoted herein. Use of any Content appearing or referenced in this publication or obtained from advertisers is voluntary, and reliance on it should only be undertaken after an independent review by qualified experts. ATA is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use of, reference to, reliance on, or performance pursuant to such Content.

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Sr. Content Editor, 469.420.2647   
Contribute news

This edition of the ATA Thyroid Weekly News Briefs was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Nov. 16, 2011
Nov. 9, 2011
Nov. 2, 2011
Oct. 26, 2011



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063